3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
3
Ovarian Neoplasms
2
Cervical Cancer Metastatic
2
Breast Neoplasms
2
Uterine Cervical Neoplasms
1
Recurrence
1
Non-squamous Non-small-cell Lung Cancer
1
Melanoma
1
Advanced Solid Tumor
1
Interventions
Radiotherapy
4
osimertinib
3
aflutinib
3
Radiosurgery
3
Pemetrexed
3
Drug Therapy
3
Carboplatin
3
toripalimab
2
pembrolizumab
2
Docetaxel
2
tislelizumab
1
sugemalimab
1
lenvatinib
1
cemiplimab
1
brigatinib
1
Vinorelbine
1
Tyrosine Kinase Inhibitors
1
Surgical Procedures, Operative
1
S 1 (combination)
1
Platinum Compounds
1
Platinum
1
Pharmaceutical Preparations
1
Paclitaxel
1
Neoadjuvant Therapy
1
JDQ443
1
Immune Checkpoint Inhibitors
1
HM781-36B
1
Gemcitabine
1
Diphenhydramine
1
Cryotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
NSCLC
×
famitinib
×
1 year
×
Clear all
No trials found.